[HTML][HTML] Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice
T Wang, D Nowrangi, L Yu, T Lu, J Tang, B Han… - Journal of …, 2018 - Springer
Background Inflammasomes are involved in diverse inflammatory diseases. Previous study
reported that the neurotransmitter dopamine inhibited NLRP3 inflammasome activation via …
reported that the neurotransmitter dopamine inhibited NLRP3 inflammasome activation via …
Activation of dopamine D2 receptor suppresses neuroinflammation through αB-crystalline by inhibition of NF-κB nuclear translocation in experimental ICH mice model
Y Zhang, Y Chen, J Wu, A Manaenko, P Yang, J Tang… - Stroke, 2015 - Am Heart Assoc
Background and Purpose—Inflammatory injury plays a critical role in intracerebral
hemorrhage (ICH)–induced secondary brain injury. Recently, dopamine D2 receptor …
hemorrhage (ICH)–induced secondary brain injury. Recently, dopamine D2 receptor …
[PDF][PDF] Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome
Inflammasomes are involved in diverse inflammatory diseases, so the activation of
inflammasomes needs to be tightly controlled to prevent excessive inflammation. However …
inflammasomes needs to be tightly controlled to prevent excessive inflammation. However …
Administration of Dexmedetomidine inhibited NLRP3 inflammasome and microglial cell activities in hippocampus of traumatic brain injury rats
B Zheng, S Zhang, Y Ying, X Guo, H Li, L Xu… - Bioscience …, 2018 - portlandpress.com
The abnormally high nucleotide-binding oligomerization domain (NOD)-like receptor family
pyrin domain containing 3 (NLRP3) inflammasome activity is a typical characteristic of …
pyrin domain containing 3 (NLRP3) inflammasome activity is a typical characteristic of …
Neuroinflammation mediated by NLRP3 inflammasome after intracerebral hemorrhage and potential therapeutic targets
L Xiao, H Zheng, J Li, Q Wang, H Sun - Molecular Neurobiology, 2020 - Springer
Intracerebral hemorrhage (ICH) is the most fatal subtype of stroke; there is still a lack of
effective treatment. Microglia are a major component of the innate immune system, and they …
effective treatment. Microglia are a major component of the innate immune system, and they …
Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3
J Zhu, Z Hu, X Han, D Wang, Q Jiang, J Ding… - Cell Death & …, 2018 - nature.com
Astrocytes are involved in the neuroinflammation of neurodegenerative diseases, such as
Parkinson's disease (PD). Among the numerous inflammatory cytokines, interleukin-1β (IL …
Parkinson's disease (PD). Among the numerous inflammatory cytokines, interleukin-1β (IL …
[HTML][HTML] Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury
Z Gong, J Pan, Q Shen, M Li, Y Peng - Journal of neuroinflammation, 2018 - Springer
Background Nod-like receptor protein 3 (NLRP3) inflammasome is a crucial factor in
mediating inflammatory responses after cerebral ischemia/reperfusion (I/R), but the cellular …
mediating inflammatory responses after cerebral ischemia/reperfusion (I/R), but the cellular …
[HTML][HTML] Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB …
J Liu, W Ma, CH Zang, GD Wang… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background The NOD-like receptor family pyrin domain-containing 3 (NLRP3)
inflammasome is an important mediator of neuroinflammatory responses that regulates …
inflammasome is an important mediator of neuroinflammatory responses that regulates …
NLRP3 inflammasome in the pathophysiology of hemorrhagic stroke: a review
Y Luo, C Reis, S Chen - Current neuropharmacology, 2019 - ingentaconnect.com
Hemorrhagic stroke is a devastating disease with high morbidity and mortality. There is still a
lack of effective therapeutic approach. The recent studies have shown that the innate …
lack of effective therapeutic approach. The recent studies have shown that the innate …
Dopamine D1 receptor agonist A-68930 inhibits NLRP3 inflammasome activation, controls inflammation, and alleviates histopathology in a rat model of spinal cord …
W Jiang, Y Huang, F He, J Liu, M Li, T Sun, W Ren… - Spine, 2016 - journals.lww.com
Study Design. A randomized experimental study. Objective. The aim of this study was to
investigate the therapeutic efficacy and molecular mechanisms of dopamine D1 receptor …
investigate the therapeutic efficacy and molecular mechanisms of dopamine D1 receptor …